Trial Profile
Phase II, Open Study, Exploratory Examination of Efficacy and Safety of Paricalcitol Injection and Maxacalcitol Injection in Chronic Kidney Disease Subjects Receiving Haemodialysis With Secondary Hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary) ; Maxacalcitol
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 18 Jun 2014 New trial record
- 25 May 2010
- 18 Mar 2010